COVID-19

COVID Vaccine
Health, Latest Now

What happened If I miss my 2nd dose of my COVID vaccine

Two of the at present supported COVID-19 immunizations, the Pfizer and Moderna antibodies, give solid insurance against COVID-19, however acquiring the full defensive advantage of either immunization requires getting two shots — and the circumstance between these dosages is significant.   The suggested span between the first and second portion is: Three weeks (21 days) separated for Pfizer-BioNTech. A month (28 days) separated for Moderna.   And keeping in mind that it’s ideal to get your second portion on time…stuff occurs. Perhaps you got COVID-19 not long after your first portion and need to recuperate prior to getting your subsequent one. Possibly you even got monoclonal neutralizer treatment or recuperating plasma while sick and need to stand by 90 days before your subsequent portion. Or on the other hand perhaps an individual emergency or catastrophic event kept you from making it to your arrangement for your subsequent portion. All in all, what occurs if your second COVID-19 antibody portion is postponed because of something unavoidable? This is what you need to know whether you miss your second COVID-19 immunization portion. If a circumstance that is out of your control emerges and makes you miss your subsequent portion, don’t freeze. “It’s ideal to get your second portion as near the suggested stretch as could really be expected. Be that as it may, if a postponement is unavoidable, missing this window doesn’t mean you’ve botched your lone opportunity of getting your subsequent portion. It likewise doesn’t mean you need to begin your inoculation plan once again totally,” says Dr. Ashley Drews, clinical overseer of contamination counteraction and control at Houston Methodist. As per the CDC, when following the suggested rules isn’t attainable, the second portion of either the Pfizer or Moderna antibody can be directed if about a month and a half after the first. “What we don’t know is the way viable either immunization is when postponed past about a month and a half, however getting your subsequent portion is as yet prescribed and prone to be gainful,” Dr. Drews says. “Regardless of whether your subsequent portion is altogether postponed, you don’t have to begin the immunization arrangement all finished. You ought to simply get the subsequent portion to finish the arrangement quickly.” The primary concern: If you missed your arrangement for your subsequent portion, contact the immunization wholesaler to reschedule straightaway. With regards to getting your subsequent portion on schedule, find ways to keep away from the avoidable There will consistently be things in life you can’t handle, so it’s critical to assume responsibility for the things that you can. Since the circumstance between COVID-19 immunization dosages may affect the antibody’s viability, it’s critical to find ways to help guarantee you get your second portion on time. Here are three things you can never really ensure you get your subsequent portion on schedule: Check your schedule prior to planning your first portion. When making your arrangement for your first portion, be certain that in three weeks’ time (Pfizer) or a month’s time (Moderna) you’re accessible to come in for your subsequent one. You may not know which immunization you’re stretching out beyond time, so be certain you’re free and accessible both three and a month out. Leave your first meeting with your subsequent arrangement planned. The cycle for planning your subsequent portion will differ contingent upon where you get immunized, however don’t stop for a second to pose inquiries about the interaction if it’s not effectively clarified to you. Preferably, don’t leave your first arrangement without having your subsequent one planned. Know which antibody you got. The Pfizer and Moderna antibodies have diverse suggested measurements spans, and the two immunizations are not exchangeable. While at your arrangement, remember to ask which antibody you’re getting. This data will help you keep steady over the circumstance for your subsequent portion, particularly if your inoculation site doesn’t permit you to plan your second portion right away.

Covid
Coronavirus, Latest Now, World

Why COVID-19 is Spiking?

Instances of the novel Covid are spiking in practically 50% of the United States at this moment, as per CNN. Indeed, in any event 21 states saw a spike in COVID-19 cases inside the most recent week.   For what reason is COVID-19 spiking? The nation keeps on carrying out COVID-19 immunizations to many individuals consistently. Yet, that doesn’t mean the pandemic is over in the smallest, particularly with COVID-19 variations coasting out there and antibody reluctance. “Nonetheless, between fluctuating paces of immunization reluctance and the speed of inoculations, the course of events for inoculating all willing grown-ups changes extraordinarily among states — a developing concern on the grounds that, for certain areas, another flood may have shown up,” CNN reports. Dr. Earth Marsh, West Virginia’s COVID-19 ruler, revealed to CNN the United States saw a drop in COVID-19 cases in the start of the year on account of the immunization. Presently, apparently another flood of cases has hit the United States. “We realize that these immunizations are truly mindful fundamentally for the 90% decrease in passing we’ve seen over the initial 13 weeks of 2021,” Marsh said, as indicated by CNN.   Fourth spike There have been alerts of a fourth spike for most of a month now, as I composed for the Deseret News. Specialists were worried that the COVID-19 variations — remembering those found for Europe, Brazil, and South Africa — could make more cases in the country. Truth be told, Dr. Scott Gottlieb, the previous Food and Drug Administration chief, told CBS’s “Face the Nation” that the new spike will be generally among youngsters, who stay unvaccinated against COVID-19. “In the event that you look what’s going on in Michigan, in Minnesota, in Massachusetts, for instance, you’re seeing flare-ups in schools and contaminations in friendly partners that haven’t been presented to the infection previously.” “The disease is changing its forms regarding who’s being blasted by it at the present time,” he added.   What’s distinctive about the new COVID-19 wave? Specialists as of late disclosed to CNN that the following flood of the novel Covid may appear to be somewhat unique than what we’ve seen previously. Dr. Peter Hotez, dignitary of the National School of Tropical Medicine at Baylor College of Medicine, disclosed to CNN that variations will change the way the wave hits. “We need to consider the B.1.1.7 variation as just about a pristine infection,” he told CNN. “It’s acting uniquely in contrast to anything we’ve seen previously, as far as contagiousness, regarding influencing youngsters, so we need to treat this appropriately.”   Is the fourth influx of COVID-19 here? Previous Food and Drug Administration Commissioner Dr. Scott Gottlieb told CBS’s “Face the Nation” that youngsters will feel the brunt of the new wave since a great deal of them they stay unvaccinated because of qualification. “In the event that you look what’s going on in Michigan, in Minnesota, in Massachusetts, for instance, you’re seeing episodes in schools and contaminations in friendly partners that haven’t been presented to the infection previously.” “The disease is changing its shapes regarding who’s being blasted by it at the present time,” he added.   Will there be COVID-19 passing? Axios detailed that the impending fourth wave may have less passing than prior waves. The past waves hit more established populaces, prompting more passing from COVID-19. In any case, near 75% of more established Americans have gotten at any rate one portion of the COVID-19 immunization, which proposes that there will be a lower passing rate among the gathering during the following wave. It’s muddled how much the new variations will affect more youthful populaces — or if it they avoid the immunizations.

India Covid
Coronavirus, Latest Now, World

India is suffering from 2nd wave of COVID-19

India’s second wave of COVID-19 is way more aggressive and deadly than the primary. It took only a couple of weeks for COVID-19 complacency to show into an awesome sense of despair, anguish, and anger. Now India, sinking under a surge of cases, “feels sort of a country that’s broken”. The country has smashed global records with quite 330,000 daily infections and a daily price of quite 2,000. Countless stories of desperate people unable to urge medical treatment and other people dying after being turned far away from hospitals have engulfed the state. Not only is that the surge much more aggressive and deadly than the one India endured last year, but there’s a way stronger belief that this catastrophe could have, and will have, been easily avoided. First, there was a slower reaction to the second wave. India took swift action when the pandemic first took hold last year, imposing one among the foremost aggressive lockdowns within the world. The measures forced many economic migrants to steer vast distances to their hometowns and villages. “Last year, people were tons more willing to forgive the govt for his or her mistakes and helplessness,” journalist Barkha Dutt, from the web publication Mojo Story, said. “People were not angry with the government at the time, despite the pain, because there was a sense the whole world was snowed under a pandemic that science did not understand.” The economic scars from the lockdown have run deep and governments across India are reluctant to deploy similar methods to regulate the spread. A severe lack of masks and social distancing has made the optics of such incidents so alarming. The human disaster in India is all-consuming, with an awesome feeling that every single person during this massive country has been directly affected. The pandemic is extensive through India at a pace that has staggered scientists. Daily case numbers have exploded since early March: the govt reported 273,810 new infections nationally on 18 April. High numbers in India have also helped drive global cases to a daily high of 854,855 within the past week, almost breaking a record set in January. Just months earlier, antibody data had recommended that a lot of people in cities like Delhi and Chennai had already been infected, leading some researchers to conclude that the worst of the pandemic was over within the country. Researchers in India are now trying to pinpoint what’s behind the unprecedented surge, which might be thanks to an unfortunate confluence of things, including the emergence of particularly infectious variants, an increase in unrestricted social interactions, and low vaccine coverage. Untying the reasons might be helpful to governments trying to suppress or prevent similar surges around the world. European countries like France and Germany also are currently experiencing large outbreaks relative to their size, and nations including Brazil and therefore the us are reporting high infection rates at around 70,000 a day. But India’s daily totals are now several the best recorded for any country and aren’t faraway a peak of 300,000 cases seen within the us on 2 January. Various countries begin to help India. Several nations have reached bent support New Delhi. The us announced it might immediately provide raw materials for COVID-19 vaccines, also as therapeutics, rapid diagnostic assay kits, ventilators, and protective equipment for frontline workers. “We are working closely with our partners within the Indian government, and that we will rapidly deploy additional support to the people of India and India’s healthcare heroes,” US Secretary of State Anthony Blinken said on Twitter. Help and support has also been offered from India’s long-time foe Pakistan, with politicians, journalists and citizens within the neighboring country expressing solidarity. Pakistan’s Foreign Affairs Ministry said it offered to supply relief including ventilators, oxygen supply kits, digital X-ray machines, PPE, and related items. Ventilators, oxygen supplies, and medicines from the United Kingdom, France and therefore the EU also are thanks to arrive in India in coming days. India has ordered its soldiers to assist tackle surging new coronavirus infections, as nations including Britain, Germany and therefore the us pledged urgent medical care to undertake to contain an emergency overwhelming the country’s hospitals. The condition within the world’s second most populous country is “beyond heartbreaking”, World Health Organization chief Tedros Adhanom Ghebreyesus said on Monday (local time), adding that WHO is sending extra staff and supplies including oxygen concentrator devices.

vaccine trial magazineup
Coronavirus, Latest Now

COVID-19 -US expects to start their vaccines program soon

COVID-19 -US expects to start their vaccines program soon The Biden administration has declared that it will start shipping approximately 1 million COVID-19 immunization dosages every week specifically to thousands of drug stores to deal with value concerns and speed up the country’s vital immunization effort. The immunizations sent to drug stores are going to be in expansion to the many measurements sent week by week to states, territories and tribes which are several the time managed at neighborhood pharmacies. The program will start on Feb. 11 on a restricted premise, with immunizations sent to almost 6,500 stores across the country, Jeff Zients, the White House’s COVID-19 reaction facilitator, told columnists on Tuesday. He said that the trouble would at that time proportion which within the end of the day up to 40,000 retail drug stores, counting Walgreens, CVS and Rite Aid locations, would get measurements specifically from the govt. Once the program begins, Zients said, those wishing to urge immunization need to take after their state’s current qualification necessities and, if qualified, at that time ask their local pharmacy to ascertain within the event that there is immunization availability. In his remarks, Zients stressed that value of immunization dissemination could also be a key component of the drug store exertion. In numerous areas round the U.S., white individuals are becoming immunized at much higher rates than are individuals of color. “[Pharmacy] locales are chosen supported their capacity to succeed in a couple of of the populaces most at chance for extreme sickness from COVID-19, counting socially defenseless communities,” said Zients, who included that the Centers for Malady Control and Avoidance will screen the situation information for value concerns. The drug store program was to start with detailed by Politico. Zients, who had fairly completed a call with governors, moreover, declared a small increment within the number of dosages that states seem to anticipate over the subsequent few weeks, from 10 million doses every week to almost 10.5 million. The Biden administration had reported final week a short-term increment to 10 million measurements every week, from 8.6 million. NPR detailed Monday that vaccine-maker Moderna had made noteworthy advances in expanding its shipments to the U.S. government, whereas Pfizer, which has a licensed antibody with its German partner, BioNTech, was slacking behind. Zients also said that the Federal Emergency Management Agency would fully reimburse states for National Guard activations and other emergency provisions associated with COVID-19, going back to the start of the coronavirus outbreak, in January 2020. That funding doesn’t require congressional action and can come at a price of $3 billion to $5 billion, Zients estimated. President Biden has pledged to urge 100 million vaccine doses into arms within the first 100 days of his administration. That pace, of 1 million doses each day, is already being surpassed. White House officials have called Biden’s goal “a floor, not a ceiling.”

ca antibody 41320istock
Coronavirus

COVID-19-Why do you think BCG-vaccination

COVID-19-Why do you think BCG-vaccination would protect against COVID-19? Is it real?   COVID-19 is not only successful in infecting people around the world (1), but also obsessed people at the same time with lots of irrelevant things. Who thought this strain of COVID would be stronger than any of its parallel COVID-lines? Who thought this will be highly contagious, spreading with a record speed? Who thought it could be as potent as it stays outside host for hours to days? Who thought it could infect not only immune-compromised people or older people but also people at any age? Who thought this virus could be using healthy human as the best carrier when traveling country to country? Who thought this not only attacks respiratory system but also travel through gastrointestinal tract? Who thought about insisting people “not using face mask” could be dangerous?   No one knew any of these questions or if knew, gave wrong solutions! The list is getting longer and longer. As a matter of fact, now BCG-vaccination is becoming a topic around the world in the context of COVID-19 infection whether western world made a great mistake not practicing BCG-vaccination as part of routine vaccination strategy, with a speculation that BCG-vaccination reduces number of cases of COVID-19 (2). Surprisingly, whether it is true or false, some part of the world (Asia) are not seeing aggressive nature of COVID-19 cases (3). Interestingly, most countries in Asia still believe BCG-vaccination program as one of the important ones protecting against tuberculosis (4). In the Western World, BCG vaccination is no longer recommended due to lack of protection by BCG-vaccination against pulmonary TB. There are also some side effects of early life BCG vaccination when it comes in the context of HIV infection. Western world stopped using BCG because BCG-vaccination induced immunity is not long lasting (5), it decays over ages. Therefore, revaccination with BCG suggested but was not successful.   What is BCG? BCG-vaccine contains live attenuated bacteria. It is given subcutaneously, but it could reach to any places in the body within a short time. Because of this unique ability, BCG-vaccination provides strong immune responses in the lungs even it is administered in a remote place. As I mentioned this vaccine was thought effective against tuberculosis. However, tuberculosis is caused by Mycobacterium tuberculosis which is a virulent pathogen, different from BCG to some extent, especially some of the antigens are missing in BCG that are present in virulent mycobacteria.   BCG-specific immunity: When it comes to the vaccination against any pathogen, generally, scientists look for specific immunity to raise by the vaccination. Since tuberculosis causing pathogen is an intracellular, meaning immune cells capture mycobacteria and try to kill it while inside by using their machineries. It is believed that T cell-based immunity (type-1) is very effective in killing tuberculosis pathogen. Since this infection is a respiratory, people thought of inducing specific immunity by giving BCG-vaccination through intranasal route. Unfortunately, intranasal route of administration of BCG is not safe especially for children. One, remarkable observation is that even BCG- vaccination is not very effective against pulmonary (lung) TB, this still very effective against other forms of tuberculosis, not formed in the lungs. This is why third world countries still keep BCG as their routine vaccination strategy.   Why BCG-induced immunity would be effective against COVID-19? COVID-19 is completely different pathogen and does not show any similarities with tuberculosis or BCG. There is no scientific evidence yet showing BCG-induced immunity could prevent COVID-19 infection further to spread. Like many other COVIDs, COVID-19 is using similar route to attack humans, displaying symptoms like common cold. Only difference with COVID-19 is that it could lead to aggressive lung infection and results in pneumonia like symptoms. To prevent viral infection, scientists would allow natural immunity to develop because there is no effective medication or successful vaccines available against such flu-like virus. Every year we received vaccines against flu (influenza) which are either not effective or sometimes only effective partially. Interestingly, this virus acquires genetic modification so rapidly and because of this fact ultimately one particular vaccine against same virus may not work for the next year. This is a common problem and perhaps one biggest challenge in the development of vaccine against COVID-19 (6). Now, when a specific vaccine is not working against COVIDs, how one could think BCG-vaccination will provide protection against another pathogen like COVID-19?   Immune response either naturally induced or vaccination-induced, is very complex in nature. Generally two types of immunity can be seen: innate (rapid and non-specific) and adaptive (specific-long-lived). The only advantage of BCG-vaccination is that due to the nature of this vaccine, it induces very strong innate immunity and it is stronger than any other form of vaccines in the history. At the same time, BCG could also act as an adjuvant, meaning could help other vaccines when giving at the same time or in a strategy called prime-boost vaccination. BCG can work as a very good candidate to prime the immune system. When the term ‘priming’ comes, it induces strong innate immune responses, which is generally important to let adaptive immune cells to know. This collaborative effort is very necessary to use all of the tools of the immune system in order to generate effective immune response.   Virus-induced natural immunity: Most of this seasonal flu-virus induced immunity is developed with a week or two. Scientist also aim for inducing humoral (specific antibody) immune responses when targeting vaccine against any of this virus. Since a majority of population are naturally protective against common flu, it is thought that antibody mediated protection is the key, because specific antibody can neutralize the virus. Thus, in the context of BCG-vaccination, one key question is does BCG-vaccination induce specific antibody responses against COVID-19? The answer is likely ‘NO’. But one possibility is that BCG-vaccination is very unique in the sense that this could induce lots of cross-reactive antibodies in the body. This cross-reactive responses sometimes could be effective

covid 19
World

COVID-19 diagnosis and reporting: why this is so important?

COVID-19   Like many other countries, Bangladesh is now started seeing more cases of COVID-19, it might sound like less number of positive cases and late diagnosis. We all need to keep in mind that, this has been same in all other countries including USA, where this slow rate of diagnosis has been pushed so much within a week that crossed the maximum number of diagnosis/day/week than any other countries. One obvious question is why to do this diagnosis even everybody is saying there is no specific treatment? Whether a person is diagnosed or not, only one recommendation is ‘STAY HOME’. We might not be aware that early diagnosis of COVID-19 is critical, before spreading to the community and now this phase has been passed in Bangladesh. So, why still diagnosis is needed? Diagnosis is still critical in global point of view. This means COVID-19 has a clear ‘incubation time’ within human as a host. This means following incubation (14 days) there could be possibly two outcomes: some may get sick showing symptoms or some may remain healthy. Remember this 14 days incubation should start theoretically “when people locked in one place”, which is realistically impossible due to the fact that we would not listen that all at once. Because of that we lost track where to set the clock. As a result, instead of 14 days, it might go longer. But still, under this situation, once we know the number of cases in the country, we would be able to see the ‘PEAK’ of cases in next couple of weeks. If we all are very obedient, this will soon be turning around. This means the number of new cases will be lower. “Flattened COVID-19 curve” what that tells? This is a good news for any country because under ‘HOME STAY’ condition there is less spread because virus didn’t find new host. So, locating this time point will tell us approximately when we probably can mentally be ready to open the country. Now, you can assume how critical this data is for a country because any mistake or lack or enough data will significantly affect the future. Who should perform this duty? This should be under direct supervision of Bangladesh Primer Minister with a task force#1 built with Research scientists, few doctors and supervisor of law-enforcement groups. Since there are number of labs around the country getting samples and performing diagnosis tests, all results should be sent to the task force for visualization of COVID-19 progression. Task force#2: Only the Research Scientists will be in this task force for better coordination, accumulation of results and presentation. They need to perhaps discuss more often because of the nature of this tests. Accurate sampling, testing and safety all need to be monitored by the group of scientists by teleworking.   Monitoring diagnostic test results and expectations: COVID-19 diagnostic kits for 100 samples do not mean to successfully run 100 samples. Why? In Bangladesh context, this is super critical to understand that a test kit to be used for 100 samples should not put pressure on the lab workers to generate 100 results in your final report. Govt. People also need to understand that very well. You are running samples from patients that are with different amounts of viral load. This means some samples though had symptoms might be with very low amount of material and could give confusing results. So lab workers need to repeat the test. They should not be driven by any force that we don’t have enough reagents and whatever data you got tell us it is positive or negative. If that happens would be a total disaster. So, Kits made for 100 samples (#100 just give a number for a comparison) would never generate 100 test results as final. It will be always less. This is the reality. If the Diagnosis test becomes a nightmare? Below seems to be a qPCR amplification chart. I believe it is from recent COVID-19 infected patient samples. It’s clear from the amplification curve but sounds like almost no amplification >35cycles. If that data was used to demonstrate positive case, this is unreliable. Who is in the frontline of performing this test, needs to be careful and make sure whatever kit you are using you are reproducing your positive curve provided by the kit. Make sure your negative samples not get amplified. It is expected to have data like below in each of your tests but important NOT to draw conclusion. It is really important to be supervised by each of the diagnosis results by experts. Unfortunately this test takes lots steps and need to be done carefully. Ct cycle needs to be taken as an key to determine the positive or negative due to variation in the template concentration coming from all different patients. One critical thing when it goes to many hands and dealing with lots of samples, a little amount of DNA contamination from other samples could also lead that high Ct. values. So, consensus should be to repeat that samples for the sake of patients.        

coronavirus 4810201 1920 678x509 1
Coronavirus

COVID-19 The Planet turned into an experimental laboratory

COVID-19: the Planet turned into an experimental laboratory and human became the testing subjects (‘Herd immunity’ vs ‘NO immunity’)   The spread of COVID-19 infection turned the world into a human laboratory. I know you don’t want to be part of this experiment but you like to hear about the results of an ongoing experiment around the globe. Maybe it is time to share how scientists in the laboratory perform an experiment. Generally, it is really not a big deal about knowing something that is not your area of interest. But it is a big deal to develop a system with maximum accuracy in any discipline because people expect to see that the system should work with full potential and accuracy. Therefore, whatever you do or wherever you might belong to there are some inherent steps that are obligatory to maintain. Because of the nature of COVID-19 transmission, it is highly recommended in each country to either maintain social distancing (voluntarily) or set extraordinary restrictions on free movement or any sort of assembly. This is our experiment and we all are part of it. But if you go deeper and deeper how an experiment is designed and finally performed in the laboratory is not just like that. The experiments require many fundamental basics to meet before you perform it. Otherwise, it could easily give you a result that cannot be useful or sometimes very detrimental. Depending on the nature of a laboratory experiment one should carefully plan the experiment. For instance, imagine you would like to test a vaccine in mice, the first thing is that these experimental mice need to be housed in a clean environment, with good health, access to food and water and so on. Those are the basics needs before mice receive a vaccine injection. After vaccination, the mice immune systems will react and develop immunity which does need certain time. To confirm if the vaccine is working or not, there are some laboratory testing needed to perform before you announce the results. Unfortunately, either due to lack of knowledge or due to many shortcomings, our planet experiment design was pretty sloppy. There is a number of reasons for that: 1. It is a large scale experiment and no history was available previously 2. Experts never thought we were undergoing an experiment but indeed we are now.. 3. No significant knowledge about the speed of transmission of COVID-19 4. No prediction about who will get infected and who will be vulnerable and who will be recovered 5. Lack of prediction on whether to use a mask or not but declared using a mask, in general, is harmful 6. Of course no medication available All of these above are significant limitations that drove the world into ‘Quarantine’ mode. Few countries showed that extreme social distancing and complete lockdown potentially reduces the cases and spread to the community. For example, South Korea, China was very successful. Because they performed their experiment by maintaining the standard. Other countries, impose FAKE social distancing and finally lockdown but unfortunately, it was late to limit the spread of the infection. Like, USA, Italy, Spain didn’t follow the basic standard of an experiment and it turned out to generate results that are BAD RESULTS. Interestingly, one lesson from ‘BAD data’ is that you can think of sorting the flaws out and do the experiment in a proper way. Some countries still have that opportunity to take the findings seriously to perform their own experiment. One country on the planet, Sweden is doing a completely different experiment, which is following social distancing only at a very minimal level. It is not that Sweden is not hit by the virus but the cases are relatively low when you compare with other EU countries like Germany, Spain, Italy. Interestingly, Swedes believe in ‘Herd Immunity’. What is ‘Herd Immunity” Herd immunity is something that let people develop immunity against infection or foreign pathogens by natural exposure. So, instead of saying people ‘STAY HOME’ they give the freedom of choice to the people to do normal business, daily work so that enough people become immune against COVID-19. This experiment is not bad but again, this didn’t follow the standard criteria of performing an experiment. For example, This hypothesis is too early to test in the community because there is not much knowledge about this virus in terms of nature of transmission (already found in the stool), colonization and viral load, fitness in the environment, interaction in the upper or lower respiratory tract, and most importantly, when and what type of immune responses would be protective and available in the human body and what group (age) of people will generate this protective immune response are still not available. Sweden is a big country relative to the total number of population. They do have already unwanted social distancing in the society in place to some extent which is comparable to what we in other countries are practicing now. We should not compare Apple to Orange, but it is time to think cautiously. Even under lots of privileges, Sweden is not up to the mark of Diagnosis of COVID-19 cases and people with symptoms strictly advised to ‘STAY HOME’. This is not the time to test a hypothesis in the general population by taking risk of elderly people’s life and letting younger to generate Herd Immunity. Lots of scientific evidence are desperately needed to go that direction.   Dr. Jubayer Rahman (PhD in Infectious Immunology), Maryland, USA

coronavirus 4817439 19201
World

Novel coronavirus spread and how can you protect yourself?

COVID-19 spreads from person to person in close immediacy, almost like other respiratory illnesses. Public health expert SAID Prepare for coronavirus, but don’t terrify.The new coronavirus continues to spread around the world, prompting governments to step-up efforts to contain the increase of the disease it causes, officially referred to as COVID-19. How is that the coronavirus spreading? The coronavirus – referred to as COVID-19 – spreads from person to person in close proximity, almost like other respiratory illnesses, like the flu. Droplets of saliva or mucus – from an infected person are dispersed within the air or on surfaces by coughing or sneezing. These droplets can inherit direct contact with people or can infect those that pick them up by touching infected surfaces then their face. According to researchers, coughs and sneezes can travel several feet and stay suspended within the air for up to 10 minutes. It is not yet known how long the virus can survive outside a host but, in other viruses, it ranges from a couple of hours to months. Transmission is of specific concern on transport, where droplets containing the coronavirus could pass between passengers or via surfaces like aeroplane seats and armrests. The maturation period of the coronavirus, the length of time before symptoms appear, is between one and 14 days. Although not yet confirmed, Chinese health authorities believe the virus are often transmitted before symptoms appear.” Can people be immune to the novel coronavirus? Viruses that spread rapidly usually come with lower mortality rates and vice versa. As the virus is a completely new strain, it’s believed that there’s no existing immunity in anyone it’ll encounter. Some level of immunity will naturally develop over time, but this suggests that those with compromised immune systems, like the elderly or sick, are most in danger of becoming severely ill or dying from the coronavirus. Although the entire number of deaths has now exceeded those recorded during the 2002-2003 outbreak of severe acute respiratory syndrome (SARS), the present death rate is much less than that of SARS. The coronavirus death rate stands at 2.4 percent, while SARS killed 9.6 percent of these infected. What is being done to prevent the spread, and when will a vaccine become available? China has placed Wuhan and entirely a dozen other cities under lockdown, affecting quite 60 million people, although this has not prevented the virus from spreading to all or any of China’s provinces. As the number of complete cases continues to climb, businesses and countries are taking increasingly drastic action. Person-to-person transmission has been confirmed in numerous countries, which WHO emergency chief Michael Ryan has called a “great concern”. Even with recent advances in medical technology, it’s unlikely a vaccine might be available for mass distribution within a year. This means that public health measures to contain the spread are going to be crucial to contain the outbreak. Restrictions on movement won’t stop the spread of the disease entirely but will slow its progress and delay for areas that have avoided infection to organize . it’ll also limit the strain on health infrastructure by reducing the amount of infections at anybody time, said Krause. Globally, quite 95,000 people are diagnosed with the disease, the  majority in China, with 3,015 deaths in China and 267 deaths across the world , many in Italy and Iran.Global economic losses could reach $347bn The new coronavirus outbreak could end in global economic losses of up to $347bn, consistent with a report by the Asian Development Bank (ADB). The minimum losses are projected at $77bn, or 0.1 percent of worldwide gross domestic product (GDP) while the utmost losses represent 0.4 percent of worldwide GDP, the ADB said. Some pet owners in China are fitting their dogs with tiny face masks, but Gray said there’s no — actually , it’s probably fairly distressing for the pet and will cause them to panic. Instead, pet owners should stick with the basics: good hygiene. Both WHO and gray said owners should wash their hands with soap and water after touching pets. Gray said if dog owners are particularly concerned, they will wipe their dog’s paws with antiseptic wipes after they need had a walk outside — but they should lookout to not overdo it, as wiping too much can dry out a dog’s paws. “I know dogs will not be infected, but if the virus goes on their skin or fur, it will stay there. So if we are careful, I think it’s OK Basic protective measures against the new coronavirus Stay conscious of the newest information on the COVID-19 outbreak, available on the WHO website and through your national and local public health authority. COVID-19 remains affecting mostly people in China with some outbreaks in other countries. most of the people who become infected experience mild illness and recover, but it can be more severe for others. lookout of your health and protect others by doing the following: Wash your hands frequently Regularly and thoroughly clean your hands with an alcohol-based hand rub or wash them with soap and water. Why? Washing your hands with soap and water or using alcohol-based hand rub kills viruses which will get on your hands. Maintain social distancing Maintain a minimum of 1 meter (3 feet) distance between yourself and anyone who is coughing or sneezing. Why? When someone coughs or sneezes they spray small liquid droplets from their nose or mouth which can contain viruses. If you’re too close, you’ll inhale the droplets, including the COVID-19 virus if the person coughing has the disease. Avoid touching eyes, nose, and mouth Why? Hands touch many surfaces and can pick up viruses. Once contaminated, hands can transfer the virus to your eyes, nose, or mouth. From there, the virus can enter your body and may cause you to sick. Practice respiratory hygiene Make sure you, and the people around you, follow good respiratory hygiene. Make sure to cover your mouth and nose together with your bent elbow or tissue once you cough or sneeze. Then eliminate the used tissue immediately. Why? Droplets spread viruses. By following good respiratory hygiene you protect the people around you from viruses like cold, flu and COVID-19. If you’ve got fever, cough, and difficulty breathing, seek medical aid early Stay home if you are feeling unwell. If you’ve got a fever, cough, and difficulty breathing, seek medical attention, and call in advance. Follow the directions of your local health authority. Why? National and native authorities will have the most up so far information on things in your area. Calling beforehand will allow your health care provider to quickly direct you to the proper clinic. this may also protect you and help prevent the spread of viruses and other infections. Stay informed and follow the advice given by your healthcare provider Stay informed on the newest developments about COVID-19. Follow the advice given by your healthcare provider, your national and native public health authority, or your employer on the way to protect yourself et al. from COVID-19. Why? National and native authorities will have the foremost up so far information on whether COVID-19 is spreading in your area. they’re best placed to advise on what

test tube 5065426 1920 scaled
Health & Lifestyle

COVID-19: the Planet turned into an experimental laboratory

COVID-19: the Planet turned into an experimental laboratory and human became the testing subjects (‘Herd immunity’ vs ‘NO immunity’) The spread of COVID-19 infection turned the world into a human laboratory. I know you don’t want to be part of this experiment but you like to hear about the results of an ongoing experiment around the globe. Maybe it is time to share how scientists in the laboratory perform an experiment. Generally, it is really not a big deal about knowing something that is not your area of interest. But it is a big deal to develop a system with maximum accuracy in any discipline because people expect to see that the system should work with full potential and accuracy. Therefore, whatever you do or wherever you might belong to there are some inherent steps that are obligatory to maintain. Because of the nature of COVID-19 transmission, it is highly recommended in each country to either maintain social distancing (voluntarily) or set extraordinary restrictions on free movement or any sort of assembly. This is our experiment and we all are part of it. But if you go deeper and deeper how an experiment is designed and finally performed in the laboratory is not just like that. The experiments require many fundamental basics to meet before you perform it. Otherwise, it could easily give you a result that cannot be useful or sometimes very detrimental. Depending on the nature of a laboratory experiment one should carefully plan the experiment. For instance, imagine you would like to test a vaccine in mice, the first thing is that these experimental mice need to be housed in a clean environment, with good health, access to food and water and so on. Those are the basics needs before mice receive a vaccine injection. After vaccination, the mice’s immune systems will react and develop immunity which does need a certain time. To confirm if the vaccine is working or not, there are some laboratory testing needed to perform before you announce the results. Unfortunately, either due to lack of knowledge or due to many shortcomings, our planet experiment design was pretty sloppy. There is a number of reasons for that: 1. It is a large scale experiment and no history was available previously 2. Experts never thought we were undergoing an experiment but indeed we are now.. 3. No significant knowledge about the speed of transmission of COVID-19 4. No prediction about who will get infected and who will be vulnerable and who will be recovered 5. Lack of prediction on whether to use a mask or not but declared using a mask, in general, is harmful 6. Of course no medication available All of these above are significant limitations that drove the world into ‘Quarantine’ mode. Few countries showed that extreme social distancing and complete lockdown potentially reduces the cases and spread to the community. For example, South Korea, China was very successful. Because they performed their experiment by maintaining the standard. Other countries, impose FAKE social distancing and finally lockdown but unfortunately, it was late to limit the spread of the infection. Like, USA, Italy, Spain didn’t follow the basic standard of an experiment and it turned out to generate results that are BAD RESULTS. Interestingly, one lesson from ‘BAD data’ is that you can think of sorting the flaws out and do the experiment in a proper way. Some countries still have that opportunity to take the findings seriously to perform their own experiment. One country on the planet, Sweden is doing a completely different experiment, which is following social distancing only at a very minimal level. It is not that Sweden is not hit by the virus but the cases are relatively low when you compare with other EU countries like Germany, Spain, Italy. Interestingly, Swedes believe in ‘Herd Immunity’. What is ‘Herd Immunity” Herd immunity is something that lets people develop immunity against infection or foreign pathogens by natural exposure. So, instead of saying people ‘STAY HOME’ they give the freedom of choice to the people to do normal business, daily work so that enough people become immune against COVID-19. This experiment is not bad but again, this didn’t follow the standard criteria of performing an experiment. For example, This hypothesis is too early to test in the community because there is not much knowledge about this virus in terms of nature of transmission (already found in the stool), colonization and viral load, fitness in the environment, interaction in the upper or lower respiratory tract, and most importantly, when and what type of immune responses would be protective and available in the human body and what group (age) of people will generate this protective immune response are still not available. Sweden is a big country relative to the total number of population. They do have already unwanted social distancing in the society in place to some extent which is comparable to what we in other countries are practicing now. We should not compare Apple to Orange, but it is time to think cautiously. Even under lots of privileges, Sweden is not up to the mark of Diagnosis of COVID-19 cases and people with symptoms strictly advised to ‘STAY HOME’. This is not the time to test the hypothesis in the general population by taking risk of elderly people’s lives and letting younger to generate Herd Immunity. Lots of scientific evidence are desperately needed to go that direction. BY Dr. Jubayer Rahman (PhD in Infectious Immunology), Maryland, USA

man holding a vaccine with woman holding a covid19 poster 3952219 scaled
Health & Lifestyle

Searching COVID-19 specific antibodies: where is our hope?

Antibodies- Never give up; this is where hope stands. Antibody research is one of the oldest parts of the scientific community. People who work in this field must know how important this research is! Most of the routine vaccines that we are giving to infants and toddlers are relying on antibodies. This is usually done by educating the immune system early-life by exposing to a small dose of molecules originated from virus/bacteria, so that the immune system can recognize later and get ready to fight against the actual attack in the future. As science made extraordinary progress during the last decades, antibody research is more focused on the laboratory as a tool to assist other new modern techniques. People have not forgotten the contribution of antibody research; it is slightly shifted towards a different direction, mainly when new and more complex diseases emerged, and clearly, the role of antibody in that context was questionable. This is because scientists found cell-mediated immune responses are more effective against those diseases like cancer, autoimmune diseases, etc.    A simple classification of human immunity: There are two distinct arms in the human immune system that work in collaboration to keep us protected. One is called innate immunity, which is very fast in action but non-specific and knock germs out very efficiently. But innate immune responses are short-lived and cannot remember who attacked first. Therefore, every time when a person encounters either the same pathogen or a different one, the response likely to be the same. Second, another arm of immunity is called adaptive responses, which are further classified into two groups: cellular and humoral or antibody-driven. This adaptive immunity comes late but could be very specific to a pathogen and can remember when next time a person is exposed to the same pathogen. Because of this memory total response against the same pathogen is truly fabulous. The most exciting part of these innate and adaptive arms of the immune system is that they work in collaboration by using lots of their potential molecules that are involved in cross-talk. Because of this network that is in place in the human body, viruses, or bacteria are not always successful in establishing infection.    How does the virus gain entry to a human? Viruses are such a tiny organism that we even could not see without electron microscopy. Although they are small, they could be intense and devastating. One example is the COVID-19 virus; almost all predictions with this pathogen seem to be failed. Interestingly, COVID-19 is not really very different than other COVIDs when the genome sequencing data revealed. But as you probably know that genomic sequencing only unveils how the genetic codes are organized. It does not tell about what messages you would expect. For example, genetic sequences first transcribe and then translated to make proteins. During this process, end products like proteins undergo many modifications which are important for virus against human-resistance. One such modification can be seen in a virus envelope, which is like a shell, helping the virus to make negotiations with the prospective host. This enveloped viral surface has major consequences for viral entry because it fuses with host cell membranes together. Generally, this is thought to be achieved through a complex interaction to a specific cellular host receptor (ACEII receptor) in COVID-19 infection and results in changes in the structure of the viral spike protein that enable forming pores in the host membrane and allows the viral genomes to gain entry into the host cell. Once an entry is achieved, viral replication takes place. How does antibody help? It is not known how exactly COVID-19 gain access to the host and under what circumstances, the human immune system either fails or prevent virus entry into the cells. Based on our knowledge with other respiratory viruses, we can just speculate that if a person is not developing symptoms following COVID-19 exposure, it is likely that the innate immunity was successful in expelling the virus. In that case, there are no antibody responses. If COVID-19 is successful in replication inside the host cells, after infecting alveolar macrophages that are under the lung epithelial lining, there might be an initiation of adaptive immune response by calling other immune cells to come close and start producing antibodies, cytokines, etc. to fight against COVID-19. Since COVID is likely using the spike protein to bind with the host cell receptor, it a general expectation that a neutralizing antibody (nAb) against viral spike protein would be disrupting the viral entry to the host. Additionally, antibodies can also block viral egress by binding to glycoproteins on the infected cell surface, thus preventing viruses from budding. This is why all of the proposed vaccines against COVID-19 are aimed predominantly to induce antibody responses. Another approach in line is to develop a monoclonal antibody against COVID-19 and use it to treat patients with severe COVID-19. What is the rationale behind these aggressive ideas? As I outlined above, how our immune system works and protects us against foreign pathogens, it is the same expectation with COVID-19 that people might generate natural immunity when exposed to COVID-19. Therefore, people either recovered or never developed symptoms but exposed might have that precious protective antibody titers. The good news is that FDA in the USA already announced the approval of a plasma therapy trial at Johns Hopkins University. Takeda has announced a polyclonal hyperimmune antigen-purified antibody concentrate. Regeneron has announced pursuing a monoclonal antibody strategy using its humanized mouse antibody screening platform to produce an antibody cocktail for both therapeutic and prophylactic use. World Health Organization (WHO) has announced a large-scale effort (named SOLIDARITY II) to aggregate serological data collected in different countries and expects to post results from the initiative within the next few months. COVID-19 antibody screening and the risk? Because of the consensus that antibody responses might be the key to block COVID-19, hundreds or more private companies already made kits available in the market suggesting for diagnosis of COVID-19. The

Scroll to Top